Archive Newsletter

1. 10.02.24 -- FDA's Platform Guidance Raises Questions For mRNA Makers 10/2/2024
   10/02/24 Advancing RNA Newsletter
2. 09.26.24 -- Industrializing mRNA Therapeutics 9/26/2024

   09/26/24 Advancing RNA Newsletter

3. 09.25.24 -- Pivoting To RNA With Circio's Dr. Erik Digman Wiklund 9/25/2024
   09/25/24 Advancing RNA Newsletter
4. 09.23.24 -- Nanoparticle Enabled Formulation And Drug Delivery Solutions 9/23/2024
   09/23/24 Advancing RNA Newsletter
5. 09.18.24 -- Two "Spicy" Takeaways On The FDA's Platform Designation Guidance 9/18/2024
   09/18/24 Advancing RNA Newsletter
6. 09.17.24 -- Outsourcing Strategies To Maximize RNA-LNP Success 9/17/2024

   09/17/24 Advancing RNA Newsletter

7. 09.12.24 -- Let's Deviate From Deviations - Sterile Drugs. 9/12/2024

   09/12/24 Advancing RNA Newsletter

8. 09.11.24 -- Is This The Hardest Question Facing mRNA Therapeutics Makers? 9/11/2024
   09/11/24 Advancing RNA Newsletter
9. 09.04.24 -- Why Bridge RNA Is Taking The RNA Space By Storm 9/4/2024
   09/04/24 Advancing RNA Newsletter
10. 08.28.24 -- The RNA Challenge Keeping RNA Execs Up At Night 8/28/2024
    08/28/24 Advancing RNA Newsletter